Evidence map›Paper›PMID 38380515›Full record

ArticleJournal of endovascular therapy : an official journal of the International Society of Endovascular Specialists2025

Target Vessel-Related Outcomes in Patients Managed With Branch Thoracic Aortic Endovascular Repair.

Petroula Nana, Giuseppe Panuccio, Fiona Rohlffs, Konstantinos Spanos, Jose I Torrealba, Tilo Kölbel

Abstract read
In one paragraph

Article in Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Fenestrated Aortic Arch Endovascular Repair for Aortic Diseases Extending to Ishimaru Zones 2 and 3.Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists · 2026
    Article
  2. Factors Affecting Compression of the Left Subclavian Artery Bridging Stent In Zone 2 Fenestrated Endovascular Arch Repair.Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Petroula NanaGerman Aortic Center, Department of Vascular Medicine, University Heart and Vascular Center, UKE Hamburg, Hamburg, Germany.ORCID 0000-0001-9060-8519
Giuseppe PanuccioGerman Aortic Center, Department of Vascular Medicine, University Heart and Vascular Center, UKE Hamburg, Hamburg, Germany.ORCID 0000-0002-8477-661X
Fiona RohlffsGerman Aortic Center, Department of Vascular Medicine, University Heart and Vascular Center, UKE Hamburg, Hamburg, Germany.ORCID 0000-0002-0460-1589
Konstantinos SpanosGerman Aortic Center, Department of Vascular Medicine, University Heart and Vascular Center, UKE Hamburg, Hamburg, Germany.ORCID 0000-0003-2891-777X
Jose I TorrealbaGerman Aortic Center, Department of Vascular Medicine, University Heart and Vascular Center, UKE Hamburg, Hamburg, Germany.ORCID 0000-0001-7595-9337
Tilo KölbelGerman Aortic Center, Department of Vascular Medicine, University Heart and Vascular Center, UKE Hamburg, Hamburg, Germany.ORCID 0000-0002-9962-0204

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionData on target vessel (TV)-related outcomes in patients managed with branched thoracic endovascular aortic repair (BTEVAR) are limited. This study aimed to present the TV-related outcomes of BTEVAR in patients managed for aortic arch pathologies at 30 days and during follow-up.

methodsA retrospective analysis of consecutive patients, managed between September 1, 2011, and June 30, 2022, with custom-made aortic arch endografts (Cook Medical, Bloomington, IN, USA), presenting at least one branch configuration, were eligible. Primary outcomes were technical success, TV-related patency, and reinterventions at 30 days.

resultsIn total, 255 TVs were revascularized using branches: 107 innominate arteries (IAs), 108 left common carotid arteries (LCCAs), and 40 left subclavian arteries (LSAs). Covered stents were used as bridging stents of which 10.2% were balloon expandable. Relining, using bare-metal stents (BMS), was performed in 14.0% of IAs, 35.2% of LCCAs, and 22.5% of LSAs. Technical success on case basis was 99.2%; no failure was related to unsuccessful TV bridging. At 30 day follow-up, no TV occlusion was detected. In 5.6% of cases, a type Ic or III endoleak, attributed to TVs, was recorded. Two patients needed early branch-related reintervention. The mean follow-up was 18.3±9.2 months. Freedom from TV instability was 94.6% (standard error [SE] 2.5%] at 12 months. No TV stenosis or occlusion was detected up to 48 months of follow-up. Freedom from TV-related reinterventions was 95.4% [SE 2.4%] at 12 months.

conclusionTV stenosis or occlusion in BTEVAR cases is rare and TV-related reinterventions and instability events are mainly attributed to type Ic and III endoleak formation.Clinical ImpactPrevious studies focusing on target vessel (TV) outcomes after endovascular aortic arch repair are limited. In this study, including 255 TVs revascularized using branched arch devices, bridging was performed with covered stents, of which 90% were self-expanding. Relining was at the discretion of the operator and was 14% for the innominate, 35.2% for the left common carotid and 22.5% for the left subclavian artery branches. No 30-day occlusion was detected. The freedom from TV instability was almost 95% at 12 months. TV instability and reintervention were mainly attributed to endoleaks type Ic and IIIc.

Indexed as

Aorta, ThoracicAortic DiseasesBlood Vessel Prosthesis ImplantationEndovascular ProceduresAgedAged, 80 and overBlood Vessel ProsthesisFemaleHumansMaleMiddle AgedPostoperative ComplicationsProsthesis DesignRetrospective StudiesRisk AssessmentRisk Factorsadverse eventsaortic archbranched repairBTEVARtarget vessels

Identifiers

PMID38380515
PMCPMC12598066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.